“Efficacy and Safety of Fixed-Dose-Rate Infusions of Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer”. Journal of Analytical Oncology 4, no. 1 (January 9, 2015):  44–51. Accessed November 7, 2025. https://www.neoplasiaresearch.com/index.php/jao/article/view/242.